Clinical significance of identifying candida on cervicovaginal (pap) smears
This study was undertaken to determine the clinical significance of detecting candida on Pap smear. Clinical information was obtained from a questionnaire sent to the health care provider whenever candida was identified during the study period. Candida was identified in 309 (3.0%) of the 10,370 Pap...
Gespeichert in:
| Veröffentlicht in: | Diagnostic cytopathology 1999-07, Vol.21 (1), p.14-17 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 17 |
|---|---|
| container_issue | 1 |
| container_start_page | 14 |
| container_title | Diagnostic cytopathology |
| container_volume | 21 |
| creator | Shurbaji, M. Salah Burja, Izabela T. Sawyer Jr, William L. |
| description | This study was undertaken to determine the clinical significance of detecting candida on Pap smear. Clinical information was obtained from a questionnaire sent to the health care provider whenever candida was identified during the study period. Candida was identified in 309 (3.0%) of the 10,370 Pap smears examined. Completed questionnaires were returned on 137 (44.3%) patients. All 137 smears were reviewed. Ninety‐nine (72%) patients were asymptomatic, 29 (21%) had symptoms typical of candida infection, and nine (7%) had nonspecific symptoms. Forty‐four (32%) patients had been treated for candida during the original clinic visit. After the Pap smear reported candida, 19 (20%) of the 93 nontreated patients were contacted and treated, while 10 (11%) were scheduled for further evaluation. No action was taken on the remaining 64 (69%) patients. There was a significant association between having initial symptoms and receiving immediate treatment (P |
| doi_str_mv | 10.1002/(SICI)1097-0339(199907)21:1<14::AID-DC5>3.0.CO;2-N |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69890691</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69890691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3945-207beafd1dec4bcfb595d6d72c1710704dbc369a255bc634998a1ef8cf7df45c3</originalsourceid><addsrcrecordid>eNp9kF1v0zAUhi0EYmXwF1CuUHuRchzHcVwmpCmDUa1qBQNxeeT4ozKkSYnbQf89jjJNSJOQL-xjvX5e6yFkQWFOAbK309tltZxRkCIFxuSUSilBzDK6oBc0Xywul1fpVcXfsznMq827LF0_IZOH-FMyKQXnKQUmz8iLEH4AgMxo8ZycUciBl0An5KZqfOu1apLgt6138dhqm3Qu8ca2B-9Ovt0m8dJ4o5KuTbTt77zu7tTWt_HVdK_2syTsrOrDS_LMqSbYV_f7Ofn28cPX6lO62lwvq8tVqpnMeZqBqK1yhhqr81q7mktuCiMyTQUFAbmpNSukyjivdcFyKUtFrSu1E8blXLNz8mbk7vvu19GGA-580LZpVGu7Y8BClhIKSWPwyxjUfRdCbx3ue79T_Qkp4KAYcVCMgzMcnOGoGDOKceWIUTFGxcgQsNpghusIfX3ffqx31vyDHJ3GwOcx8Ns39vSo8v-NjwuHMTLTkenDwf55YKr-JxaCCY7f19d4W65AsBsRP_kX-eCkMg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69890691</pqid></control><display><type>article</type><title>Clinical significance of identifying candida on cervicovaginal (pap) smears</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Shurbaji, M. Salah ; Burja, Izabela T. ; Sawyer Jr, William L.</creator><creatorcontrib>Shurbaji, M. Salah ; Burja, Izabela T. ; Sawyer Jr, William L.</creatorcontrib><description>This study was undertaken to determine the clinical significance of detecting candida on Pap smear. Clinical information was obtained from a questionnaire sent to the health care provider whenever candida was identified during the study period. Candida was identified in 309 (3.0%) of the 10,370 Pap smears examined. Completed questionnaires were returned on 137 (44.3%) patients. All 137 smears were reviewed. Ninety‐nine (72%) patients were asymptomatic, 29 (21%) had symptoms typical of candida infection, and nine (7%) had nonspecific symptoms. Forty‐four (32%) patients had been treated for candida during the original clinic visit. After the Pap smear reported candida, 19 (20%) of the 93 nontreated patients were contacted and treated, while 10 (11%) were scheduled for further evaluation. No action was taken on the remaining 64 (69%) patients. There was a significant association between having initial symptoms and receiving immediate treatment (P < 0.001) and undergoing subsequent treatment or further evaluation after the Pap smear report (P < 0.001). Marked inflammation was statistically associated with symptoms (P = 0.014), but the form or number of candida organisms was not. In conclusion, the identification of Candida on Pap smear does not necessarily indicate a symptomatic infection, although the Pap smear results had a direct impact on the treatment of 21% of patients in this study and served as a confirmation for clinical treatment in another 32% who had received such treatment at the time of the original visit. Diagn. Cytopathol. 1999;21:14–17. © 1999 Wiley‐Liss, Inc.</description><identifier>ISSN: 8755-1039</identifier><identifier>EISSN: 1097-0339</identifier><identifier>DOI: 10.1002/(SICI)1097-0339(199907)21:1<14::AID-DC5>3.0.CO;2-N</identifier><identifier>PMID: 10405801</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Candida ; Candidiasis - drug therapy ; Candidiasis - microbiology ; Candidiasis - pathology ; Cervix Uteri - microbiology ; Cervix Uteri - pathology ; Female ; Humans ; Middle Aged ; Pap smear ; Papanicolaou Test ; Vagina - microbiology ; Vagina - pathology ; Vaginal Smears ; vaginitis</subject><ispartof>Diagnostic cytopathology, 1999-07, Vol.21 (1), p.14-17</ispartof><rights>Copyright © 1999 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3945-207beafd1dec4bcfb595d6d72c1710704dbc369a255bc634998a1ef8cf7df45c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291097-0339%28199907%2921%3A1%3C14%3A%3AAID-DC5%3E3.0.CO%3B2-N$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291097-0339%28199907%2921%3A1%3C14%3A%3AAID-DC5%3E3.0.CO%3B2-N$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10405801$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shurbaji, M. Salah</creatorcontrib><creatorcontrib>Burja, Izabela T.</creatorcontrib><creatorcontrib>Sawyer Jr, William L.</creatorcontrib><title>Clinical significance of identifying candida on cervicovaginal (pap) smears</title><title>Diagnostic cytopathology</title><addtitle>Diagn. Cytopathol</addtitle><description>This study was undertaken to determine the clinical significance of detecting candida on Pap smear. Clinical information was obtained from a questionnaire sent to the health care provider whenever candida was identified during the study period. Candida was identified in 309 (3.0%) of the 10,370 Pap smears examined. Completed questionnaires were returned on 137 (44.3%) patients. All 137 smears were reviewed. Ninety‐nine (72%) patients were asymptomatic, 29 (21%) had symptoms typical of candida infection, and nine (7%) had nonspecific symptoms. Forty‐four (32%) patients had been treated for candida during the original clinic visit. After the Pap smear reported candida, 19 (20%) of the 93 nontreated patients were contacted and treated, while 10 (11%) were scheduled for further evaluation. No action was taken on the remaining 64 (69%) patients. There was a significant association between having initial symptoms and receiving immediate treatment (P < 0.001) and undergoing subsequent treatment or further evaluation after the Pap smear report (P < 0.001). Marked inflammation was statistically associated with symptoms (P = 0.014), but the form or number of candida organisms was not. In conclusion, the identification of Candida on Pap smear does not necessarily indicate a symptomatic infection, although the Pap smear results had a direct impact on the treatment of 21% of patients in this study and served as a confirmation for clinical treatment in another 32% who had received such treatment at the time of the original visit. Diagn. Cytopathol. 1999;21:14–17. © 1999 Wiley‐Liss, Inc.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Candida</subject><subject>Candidiasis - drug therapy</subject><subject>Candidiasis - microbiology</subject><subject>Candidiasis - pathology</subject><subject>Cervix Uteri - microbiology</subject><subject>Cervix Uteri - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Pap smear</subject><subject>Papanicolaou Test</subject><subject>Vagina - microbiology</subject><subject>Vagina - pathology</subject><subject>Vaginal Smears</subject><subject>vaginitis</subject><issn>8755-1039</issn><issn>1097-0339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF1v0zAUhi0EYmXwF1CuUHuRchzHcVwmpCmDUa1qBQNxeeT4ozKkSYnbQf89jjJNSJOQL-xjvX5e6yFkQWFOAbK309tltZxRkCIFxuSUSilBzDK6oBc0Xywul1fpVcXfsznMq827LF0_IZOH-FMyKQXnKQUmz8iLEH4AgMxo8ZycUciBl0An5KZqfOu1apLgt6138dhqm3Qu8ca2B-9Ovt0m8dJ4o5KuTbTt77zu7tTWt_HVdK_2syTsrOrDS_LMqSbYV_f7Ofn28cPX6lO62lwvq8tVqpnMeZqBqK1yhhqr81q7mktuCiMyTQUFAbmpNSukyjivdcFyKUtFrSu1E8blXLNz8mbk7vvu19GGA-580LZpVGu7Y8BClhIKSWPwyxjUfRdCbx3ue79T_Qkp4KAYcVCMgzMcnOGoGDOKceWIUTFGxcgQsNpghusIfX3ffqx31vyDHJ3GwOcx8Ns39vSo8v-NjwuHMTLTkenDwf55YKr-JxaCCY7f19d4W65AsBsRP_kX-eCkMg</recordid><startdate>199907</startdate><enddate>199907</enddate><creator>Shurbaji, M. Salah</creator><creator>Burja, Izabela T.</creator><creator>Sawyer Jr, William L.</creator><general>John Wiley & Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199907</creationdate><title>Clinical significance of identifying candida on cervicovaginal (pap) smears</title><author>Shurbaji, M. Salah ; Burja, Izabela T. ; Sawyer Jr, William L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3945-207beafd1dec4bcfb595d6d72c1710704dbc369a255bc634998a1ef8cf7df45c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Candida</topic><topic>Candidiasis - drug therapy</topic><topic>Candidiasis - microbiology</topic><topic>Candidiasis - pathology</topic><topic>Cervix Uteri - microbiology</topic><topic>Cervix Uteri - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Pap smear</topic><topic>Papanicolaou Test</topic><topic>Vagina - microbiology</topic><topic>Vagina - pathology</topic><topic>Vaginal Smears</topic><topic>vaginitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shurbaji, M. Salah</creatorcontrib><creatorcontrib>Burja, Izabela T.</creatorcontrib><creatorcontrib>Sawyer Jr, William L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diagnostic cytopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shurbaji, M. Salah</au><au>Burja, Izabela T.</au><au>Sawyer Jr, William L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical significance of identifying candida on cervicovaginal (pap) smears</atitle><jtitle>Diagnostic cytopathology</jtitle><addtitle>Diagn. Cytopathol</addtitle><date>1999-07</date><risdate>1999</risdate><volume>21</volume><issue>1</issue><spage>14</spage><epage>17</epage><pages>14-17</pages><issn>8755-1039</issn><eissn>1097-0339</eissn><abstract>This study was undertaken to determine the clinical significance of detecting candida on Pap smear. Clinical information was obtained from a questionnaire sent to the health care provider whenever candida was identified during the study period. Candida was identified in 309 (3.0%) of the 10,370 Pap smears examined. Completed questionnaires were returned on 137 (44.3%) patients. All 137 smears were reviewed. Ninety‐nine (72%) patients were asymptomatic, 29 (21%) had symptoms typical of candida infection, and nine (7%) had nonspecific symptoms. Forty‐four (32%) patients had been treated for candida during the original clinic visit. After the Pap smear reported candida, 19 (20%) of the 93 nontreated patients were contacted and treated, while 10 (11%) were scheduled for further evaluation. No action was taken on the remaining 64 (69%) patients. There was a significant association between having initial symptoms and receiving immediate treatment (P < 0.001) and undergoing subsequent treatment or further evaluation after the Pap smear report (P < 0.001). Marked inflammation was statistically associated with symptoms (P = 0.014), but the form or number of candida organisms was not. In conclusion, the identification of Candida on Pap smear does not necessarily indicate a symptomatic infection, although the Pap smear results had a direct impact on the treatment of 21% of patients in this study and served as a confirmation for clinical treatment in another 32% who had received such treatment at the time of the original visit. Diagn. Cytopathol. 1999;21:14–17. © 1999 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>10405801</pmid><doi>10.1002/(SICI)1097-0339(199907)21:1<14::AID-DC5>3.0.CO;2-N</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 8755-1039 |
| ispartof | Diagnostic cytopathology, 1999-07, Vol.21 (1), p.14-17 |
| issn | 8755-1039 1097-0339 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69890691 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Adolescent Adult Aged Aged, 80 and over Candida Candidiasis - drug therapy Candidiasis - microbiology Candidiasis - pathology Cervix Uteri - microbiology Cervix Uteri - pathology Female Humans Middle Aged Pap smear Papanicolaou Test Vagina - microbiology Vagina - pathology Vaginal Smears vaginitis |
| title | Clinical significance of identifying candida on cervicovaginal (pap) smears |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A47%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20significance%20of%20identifying%20candida%20on%20cervicovaginal%20(pap)%20smears&rft.jtitle=Diagnostic%20cytopathology&rft.au=Shurbaji,%20M.%20Salah&rft.date=1999-07&rft.volume=21&rft.issue=1&rft.spage=14&rft.epage=17&rft.pages=14-17&rft.issn=8755-1039&rft.eissn=1097-0339&rft_id=info:doi/10.1002/(SICI)1097-0339(199907)21:1%3C14::AID-DC5%3E3.0.CO;2-N&rft_dat=%3Cproquest_cross%3E69890691%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69890691&rft_id=info:pmid/10405801&rfr_iscdi=true |